α(1,3)-Fucosyltransferases FUT4 and FUT7 Control Murine Susceptibility to Thrombosis

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2013 Apr 9

PMID 23562273

Citations 6

Authors

Huili Wang

Maria Morales-Levy

Jason Rose

Lantz C Mackey

Peter Bodary

Daniel Eitzman

Jonathon W Homeister

Affiliations

Soon will be listed here.

Abstract

The α(1,3)-fucosyltransferases, types IV and VII (FUT4 and FUT7, respectively), are required for the synthesis of functional selectin-type leukocyte adhesion molecule ligands. The selectins and their ligands modulate leukocyte trafficking, and P-selectin and its ligand, P-selectin glycoprotein ligand-1, can modulate hemostasis and thrombosis. Regulation of thrombosis by FUT4 and/or FUT7 activity was examined in mouse models of carotid artery thrombosis and collagen/epinephrine-induced thromboembolism. Mice lacking both FUT4 and FUT7 (Fut(-/-) mice) had a shorter time to occlusive thrombus formation in the injured carotid artery and a higher mortality due to collagen/epinephrine-induced pulmonary thromboemboli. Mice lacking P-selectin or P-selectin glycoprotein ligand-1 did not have a prothrombotic phenotype. Whole blood platelet aggregation was enhanced, and plasma fibrinogen content, clot weight, and clot strength were increased in Fut(-/-) mice, and in vitro clot lysis was reduced compared with wild type. Fut4(-/-), but not Fut7(-/-), mice had increased pulmonary thromboembolism-induced mortality and decreased thromboemboli dissolution in vivo. These data show that FUT4 and FUT7 activity regulates thrombosis in a P-selectin- and P-selectin glycoprotein ligand-1-independent manner and suggest that FUT4 activity is important for thrombolysis.

Citing Articles

Non-targeted N-glycome profiling reveals multiple layers of organ-specific diversity in mice.

Helm J, Mereiter S, Oliveira T, Gattinger A, Markovitz D, Penninger J Nat Commun. 2024; 15(1):9725.

PMID: 39521793 PMC: 11550822. DOI: 10.1038/s41467-024-54134-z.

Non-targeted isomer-sensitive N-glycome analysis reveals new layers of organ-specific diversity in mice.

Stadlmann J, Helm J, Mereiter S, Oliveira T, Gattinger A, Markovitz D Res Sq. 2024; .

PMID: 38659835 PMC: 11042426. DOI: 10.21203/rs.3.rs-4130712/v1.

X chromosome-dependent disruption of placental regulatory networks in hybrid dwarf hamsters.

Brekke T, Moore E, Campbell-Staton S, Callahan C, Cheviron Z, Good J Genetics. 2021; 218(1).

PMID: 33710276 PMC: 8128391. DOI: 10.1093/genetics/iyab043.

Coupling of Co-expression Network Analysis and Machine Learning Validation Unearthed Potential Key Genes Involved in Rheumatoid Arthritis.

Xiao J, Wang R, Cai X, Ye Z Front Genet. 2021; 12:604714.

PMID: 33643380 PMC: 7905311. DOI: 10.3389/fgene.2021.604714.

A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy.

Liu S, Grantham A, Landry C, Granda B, Chopra R, Chakravarthy S Cancer Immunol Res. 2020; 9(1):34-49.

PMID: 33177106 PMC: 8601150. DOI: 10.1158/2326-6066.CIR-20-0080.

References

Gils A, Pedersen K, Skottrup P, Christensen A, Naessens D, Deinum J . Biochemical importance of glycosylation of plasminogen activator inhibitor-1. Thromb Haemost. 2003; 90(2):206-17. DOI: 10.1160/TH03-01-0034. View

Homeister J, Daugherty A, Lowe J . Alpha(1,3)fucosyltransferases FucT-IV and FucT-VII control susceptibility to atherosclerosis in apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol. 2004; 24(10):1897-903. DOI: 10.1161/01.ATV.0000141844.28073.df. View

Langer B, Weisel J, Dinauer P, Nagaswami C, Bell W . Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem. 1988; 263(29):15056-63. View

Larsen R, Nair R, Lowe J . A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase. Genes Dev. 1990; 4(8):1288-303. DOI: 10.1101/gad.4.8.1288. View

Fay W, Eitzman D, Shapiro A, Madison E, Ginsburg D . Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms. Blood. 1994; 83(2):351-6. View

Marquardt T, Brune T, Luhn K, Zimmer K, Korner C, Fabritz L . Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr. 1999; 134(6):681-8. PMC: 7095022. DOI: 10.1016/s0022-3476(99)70281-7. View

Djousse L, Karamohamed S, Herbert A, DAgostino R, Cupples L, Ellison R . Fucosyltransferase 3 polymorphism and atherothrombotic disease in the Framingham Offspring Study. Am Heart J. 2007; 153(4):636-9. PMC: 1865525. DOI: 10.1016/j.ahj.2006.12.015. View

Silveira J, Kalafatis M, Tracy P . Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C. Biochemistry. 2002; 41(5):1672-80. DOI: 10.1021/bi011304g. View

Oury C, Kuijpers M, Toth-Zsamboki E, Bonnefoy A, Danloy S, Vreys I . Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood. 2003; 101(10):3969-76. DOI: 10.1182/blood-2002-10-3215. View

10.

Ma B, Simala-Grant J, Taylor D . Fucosylation in prokaryotes and eukaryotes. Glycobiology. 2006; 16(12):158R-184R. DOI: 10.1093/glycob/cwl040. View

11.

Hansson K, Stenflo J . Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost. 2005; 3(12):2633-48. DOI: 10.1111/j.1538-7836.2005.01478.x. View

12.

Sather S, Kenyon K, Lefkowitz J, Liang X, Varnum B, Henson P . A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood. 2006; 109(3):1026-33. PMC: 1785151. DOI: 10.1182/blood-2006-05-021634. View

13.

Vandendries E, Furie B, Furie B . Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost. 2004; 92(3):459-66. DOI: 10.1160/TH04-05-0306. View

14.

Carrieri C, Galasso R, Semeraro F, Ammollo C, Semeraro N, Colucci M . The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood. J Thromb Haemost. 2010; 9(1):154-62. DOI: 10.1111/j.1538-7836.2010.04120.x. View

15.

Martinez M, Joffraud M, Giraud S, Baisse B, Bernimoulin M, Schapira M . Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII. J Biol Chem. 2004; 280(7):5378-90. DOI: 10.1074/jbc.M410899200. View

16.

Collet J, Montalescot G, Lesty C, Soria J, Mishal Z, Thomas D . Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler Thromb Vasc Biol. 2001; 21(1):142-8. DOI: 10.1161/01.atv.21.1.142. View

17.

Gitlin J, Homeister J, Bulgrien J, Counselman J, Curtiss L, Lowe J . Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice. Am J Pathol. 2008; 174(1):343-50. PMC: 2631346. DOI: 10.2353/ajpath.2009.080036. View

18.

Valnickova Z, Christensen T, Skottrup P, Thogersen I, Hojrup P, Enghild J . Post-translational modifications of human thrombin-activatable fibrinolysis inhibitor (TAFI): evidence for a large shift in the isoelectric point and reduced solubility upon activation. Biochemistry. 2006; 45(5):1525-35. DOI: 10.1021/bi051956v. View

19.

Ellies L, Ditto D, Levy G, Wahrenbrock M, Ginsburg D, Varki A . Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A. 2002; 99(15):10042-7. PMC: 126621. DOI: 10.1073/pnas.142005099. View

20.

Burne M, Rabb H . Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury. J Immunol. 2002; 169(5):2648-52. DOI: 10.4049/jimmunol.169.5.2648. View